Targeting Cognition in PTSD: Pregnenolone Augmentation of SSRIs
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
This study will test the therapeutic potential of augmenting a stable SSRI regimen with the
neurosteroid pregnenolone to reduce cognitive symptoms and PTSD symptoms in patients
diagnosed with PTSD.